Toronto, Canada

Teresa Clarke McGrath

This inventor holds 1 USPTO granted patent. Top assignee: Affinium Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teresa Clarke McGrath. Retrieved from https://idiyas.com/inventor/teresa-clarke-mcgrath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teresa Clarke McGrath: Innovator in Drug Target Research

Introduction

Teresa Clarke McGrath is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of drug research, particularly in identifying novel drug targets for pathogenic bacteria. Her work is essential in the ongoing battle against bacterial infections.

Latest Patents

Teresa holds 1 patent related to her innovative research. The patent focuses on purified proteins that comprise a specific amino acid sequence, which serves as a potential drug target. This invention provides valuable biochemical and biophysical characteristics of the polypeptides involved, paving the way for new therapeutic approaches.

Career Highlights

Teresa is currently associated with Affinium Pharmaceuticals, Inc., where she continues her research and development efforts. Her work at the company emphasizes the importance of scientific innovation in the pharmaceutical industry.

Collaborations

Throughout her career, Teresa has collaborated with esteemed colleagues, including Donald E Awrey and Vladimir Romanov. These partnerships have enhanced her research and contributed to the advancement of drug development.

Conclusion

Teresa Clarke McGrath is a pioneering inventor whose work in drug target research is making a significant impact in the field of medicine. Her contributions are vital for the development of new treatments for bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…